AKT1 and head and neck cancer: Finally, the annual keyword frequency heatmap revealed therapeutic focus (Paclitaxel, Immunotherapy, Cisplatin Resistance, Cetuximab), emerging themes (MicroRNA, Metastasis, Ferroptosis, AKT), and motor themes (Cetuximab Resistance, Cisplatin-resistance, Erlotinib, Cell Hypoxia), providing a comprehensive understanding of hotspots and trends in head and neck cancer resistance research.